Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
Kai Zhao(Qingdao University), Jörg W. Bartsch(Philipps University of Marburg)
Cited by 30
Related Papers
ADAM8 as a drug target in pancreatic cancer
|Nature Communications|2015|124
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
|Cell Death and Disease|2019|73
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
|Scientific Reports|2016|61
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its Aggressiveness
|Frontiers in Oncology|2022|35
Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells
|Brain Sciences|2023|8